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Improvement in pain, fatigue, and subjective 
sleep quality through sleep hygiene 
tips in patients with ﬁ bromyalgia
Aline Cristina Orlandi1, Camila Ventura2, Andrea Lopes Gallinaro3, Renata Alqualo Costa3, Laís Verderame Lage4
ABSTRACT
Objective: To evaluate the effectiveness of sleep hygiene instructions for women with fi bromyalgia. Materials and 
methods: Seventy women with fi bromyalgia completed the study. The assessment comprised the Fibromyalgia Impact 
Questionnaire (FIQ), the Pittsburgh Sleep Quality Index (PSQI), and a general questionnaire with personal data and 
lifestyle information. All patients received information about the disease and a sleep diary, but only the experimental 
group received the sleep hygiene instructions. Patients were asked to practice sleep hygiene, and, after three months, 
they were reevaluated by use of the same questionnaires. Results: The mean age in the control group was 55.2 ± 7.12 
years, and, in the experimental group, 53.5 ± 8.89 years (P = 0.392). The experimental group showed: a decrease in 
the pain Visual Analogue Scale values (P = 0.028), in fatigue (P = 0.021), and in the PSQI component 1 (P = 0.030); 
and a signifi cant reduction in the diffi culty falling asleep after waking up in the middle of the night (P = 0.031). The 
experimental group also showed an increase in the reporting percentage of “silent environment” (ranging from 42.9% 
to 68.6%), a decrease in the reporting percentage of “fairly quiet environment” (ranging from 40% to 22.9%), and a 
decrease in the reporting percentage of “noisy environment” (ranging from 17.1% to 8.6%). These changes facilitated 
falling asleep after waking up in the middle of the night. Conclusion: The sleep hygiene instructions allowed changing 
the patients’ behavior, which resulted in pain and fatigue improvement, increased subjective quality of sleep, in addition 
to facilitating falling asleep after waking up in the middle of the night.
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INTRODUCTION
Fibromyalgia (FM) is a rheumatic disease characterized by 
the presence of musculoskeletal pain and somatic symptoms, 
such as fatigue, and mood and sleep disorders, which play an 
important role in well-being. Insomnia is reported by 75% of 
the patients with FM.1
The literature suggests that, for a significant improve-
ment in sleep quality of individuals with chronic insomnia, 
the initial approach should consist of behavioral modifi-
cation through sleep hygiene.2 Behavioral therapies, such 
as sleep hygiene and cognitive therapy, which emphasize 
behavioral modification, have been studied and applied 
aiming at reducing the dose of medicines used to treat 
chronic insomnia, improving the quality of life of those 
who depend on hypnotics. Sleep hygiene comprises a set of 
instructions aimed at modifying the habits that can affect 
sleep health.3 However, there is no proof of the efficacy 
of using that technique to improve the sleep quality of 
patients with FM. Thus, this study aimed at assessing the 
effectiveness of the sleep hygiene instructions provided 
to women with FM.
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MATERIALS AND METHODS
This study included 80 female patients from the Fibromyalgia 
Outpatient Clinic of the Discipline of Rheumatology of the 
Faculdade de Medicina, Universidade de São Paulo (FMUSP) 
and from the Clínica de Fisioterapia, Universidade Cidade de 
São Paulo (Unicid). The patients from FMUSP were selected 
while waiting for their medical consultation with the rheuma-
tology team. If asked to return to another consultation within 
three months, their reassessment would be collected again 
while they waited for their medical consultation. If the time 
for a new consultation differed from three months, the patients 
would be contacted by the authors and another day scheduled 
for reassessment. Patients from Unicid were on rehabilitation 
treatment at the Clínica Escola de Fisioterapia. 
The inclusion criteria were as follows: women aged 18 
to 65 years old, diagnosed with FM according to the 1990 
American College of Rheumatology criteria.4 Women meeting 
those criteria but working at night shifts were excluded from 
the study, which was approved by the Committee on Ethics 
and Research of the Unicid (protocol # 13391640).
The patients underwent a general assessment compris-
ing personal data, personal habits, and anamnesis. Then, the 
following questionnaires were applied: the Pittsburgh Sleep 
Quality Index (PSQI),5 specifi c for assessing quality of sleep 
and validated for Brazil,6 that qualifi es the patient’s sleep 
during the previous month; and the Fibromyalgia Impact 
Questionnaire (FIQ),7 specifi c for assessing the impact of 
FM on the patient’s functional capacity and also validated 
for Brazil.8 After the assessment, the patients were randomly 
divided into two groups (control and experimental groups), by 
using envelopes containing the name of one of the two groups. 
The control group comprised 41 patients, and the experimental 
group, 39 patients. All participants provided written informed 
consent before randomization and after being informed about 
the inclusion and exclusion criteria.
After the assessment, both groups received a booklet with 
basic information about the disease. The experimental group 
was also instructed about sleep hygiene (Chart 1). Those in-
structions provided to the experimental group were obtained 
from studies on the treatment of sleep disorders in the elderly9 
and non-pharmacological treatment of chronic insomnia.3 Such 
instructions have also been used in a study applying sleep 
hygiene to patients with FM.10 In addition to providing the 
booklets with instructions about sleep hygiene, they were read 
and explained to each experimental group patient at a single 
meeting. The importance of the daily application of those 
instructions for three months was emphasized. In addition, 
all participants received a “sleep diary” and were instructed 
to describe, in the last 15 days of treatment, their nights of 
sleep and the hours preceding bedtime. After three months, 
the patients returned to the clinic to be reassessed (second 
meeting). During those three months, patients and authors 
had no contact. Both assessments were performed on medical 
consultation days, aiming at minimizing sample loss, which 
is common in prospective studies.
In the statistical analysis, the Student t test was used11 to 
compare the initial data of participants’ ages. The results from 
the PSQI, FIQ, and sleep diary were described according to 
the groups and occasions and were compared between the 
groups before and after treatment by using the Mann-Whitney 
test,11 and in each group before and after treatment by using 
the paired Wilcoxon test.11 Habits and characteristics of the 
sleep environment were described according to the groups by 
using absolute and relative frequencies, and the existence of 
an association was assessed with the chi-square test or Fisher 
exact test or the likelihood ratio test11 (the last two being used 
when the sample was insuffi cient to perform the chi-square 
test). Changes for each habit and characteristic of the sleep 
environment were described in each group and compared 
before and after the treatment by using the McNemar test.12 
Spearman correlation13 between the variation of the FIQ and 
the PSQI was calculated to assess the existence of correlation 
between them.
All data were analyzed with the SPSS for Windows, version 
15.0, adopting 5% as the signifi cance level, and illustrated with 
tables and bar graphs. 
Chart 1
Sleep hygiene instructions provided to patients of the 
experimental group
SLEEP HYGIENE INSTRUCTIONS 
Try to go to bed at the same time every day. Your body will be prepared to 
sleep always at the same time. You will fall asleep faster in the following 
weeks!
Avoid using your bedroom to work, study or eat. It should be only the 
place to sleep.
Avoid watching TV before bedtime, because it can make you anxious and 
interfere with your sleep!
Relax your mind and body for at least one hour before bedtime. Do not get 
involved with great problems at that time of the night.
Avoid coffee, tea and chocolate after 5 p.m.
Avoid alcohol close to bedtime. Although it helps you relax, it can disrupt 
sleep later; if possible, take a glass of milk.
If you smoke, refrain from smoking two to three hours before bedtime.
Try to eat light at dinner. Salads and vegetables are a good option. Greasy 
food, such as fried food, is heavier and can disrupt sleep!
(Continue...)
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RESULTS
This study assessed 80 female patients, of whom only 70 
concluded the study and were included in the analysis. Of the 
10 patients not participating in the statistical analysis, six de-
cided not to return to reassessment and four did not complete 
correctly the sleep diary. The mean age of the patients in the 
control group was 55.2 ± 7.12 years, and in the experimental 
group, 53.5 ± 8.89 years (P = 0.392).
Table 1 shows that, regarding the sleep diary, only the 
answers to question 3 in the experimental group differed 
signifi cantly from those in the control group (P = 0.031). That 
question regards the number of days the patient woke up during 
the night and had no diffi culty to fall asleep again (“Sleep 3”). 
The other questions of the sleep diary showed no signifi cant 
difference between the groups. In those questions, participants 
answered the number of days in which: it took them more than 
30 minutes to fall asleep, “Sleep 1”; it took them a long time 
to fall asleep again after waking up in the middle of the night, 
“Sleep 2”; they drank alcoholic beverages, “Sleep 4”; they ate 
inadequately, “Sleep 5”; they exercised at least three hours 
from bedtime, “Sleep 6”; they took sleeping pills, “Sleep 7”; 
and they had non-repairing sleep, “Sleep 8”. In addition, the 
SLEEP HYGIENE INSTRUCTIONS 
Keep your room’s temperature comfortable. A room too hot or cold interferes 
with quality of sleep. In addition, dress warmly to avoid possible muscle 
“contractures”.
Noise and light can lead to poor sleep. Thus, try to sleep in a silent dark 
room.
Regular physical activity can improve the quality of your sleep. But, beware, 
try to exercise in the morning or afternoon. If you exercise too close to 
bedtime, you might be too energized to fall asleep. The exercise should 
be pleasing, leaving you happy and cheered up. In addition to increasing 
the quality of your sleep, you will be ﬁ t.
Establish a bedtime routine. For example: lock the doors, brush your teeth... 
Your body gets used to this routine, and reminds you that bedtime is close, 
reducing the time you wait to fall asleep.
Warm bath close to bedtime is recommended to ﬁ ght insomnia, because 
it relaxes your mind and body.
Do not nap more than twice in the same week. This decreases the need 
for night sleep.
Make sure you always have a comfortable bed. This is important for you 
to fully relax and fall asleep.
Avoid “ﬁ ghting” with the bed. Sleep only the time sufﬁ cient for you to feel 
good. Do not stay in bed longer than necessary.
When you are sleepless, get up and do something boring or repetitive, such 
as to read an uninteresting book.
Say no to medicines! You should take sleeping pills only under medical 
supervision!
(Continuation of Chart 1) Table 1
Description of the sleep diary and comparison between the 
control and experimental groups 
Variable Group (n = 35) Mean SD P
Sleep 1
(More than 30 minutes to fall asleep)
Control
Experimental
7.06
7.49
5.95
6.35 0.805
Sleep 2
(Slept again with difﬁ culty)
Control
Experimental
5.00
6.60
6.34
6.12 0.132
Sleep 3
(Slept again easily)
Control
Experimental
5.71
2.91
6.19
4.35 0.031
Sleep 4
(Alcohol intake)
Control
Experimental
0.00
0.00
0.00
0.00 1.000
Sleep 5
(Inadequate food)
Control
Experimental
0.26
0.60
0.70
1.56 0.630
Sleep 6
(Physical activity)
Control 
Experimental
0.51
0.26
1.92
1.12 0.636
Sleep 7
(Took medicines)
Control
Experimental
4.63
6.00
6.70
6.90 0.317
Sleep 8
(Non-repairing sleep)
Control
Experimental
7.14
7.51
5.41
5.17 0.763
Day mean
(Fatigue 0-4)
Control
Experimental
2.14
2.31
0.82
0.92 0.273
Night mean
(Fatigue 0-4)
Control
Experimental
2.71
2.70
0.78
0.84 0.804
Mean “I went to bed”
(Bed time)
Control
Experimental
23.56
23.51
1.17
1.35 0.760
Mean “I got up”
(Getting-up time)
Control
Experimental
6.90
6.90
1.24
1.51 0.828
Results of the Mann-Whitney test. Signiﬁ cance: P < 0.05.
following means were calculated for both groups: mean fatigue 
during the day and during the night (“day mean” and “night 
mean”); mean bedtime (“bedtime mean”); and mean wake-up 
time (“wake-up mean”). None showed statistical differences, 
indicating that patients were equally tired, and went to bed and 
got up at similar times.
In the experimental group, in which patients received in-
formation on both the disease and sleep hygiene, reductions in 
the following measures were observed:  pain Visual Analogue 
Scale (VAS) (P = 0.028); fatigue (P = 0.021); and PSQI com-
ponent 1 (P = 0.030), which relates to the subjective quality 
of sleep. Table 2 shows the variables assessed and the PSQI 
and FIQ scores before and after the treatment in both groups.
Figure 1 shows the reduction in the median VAS values 
only in the experimental group after treatment. Figure 2 shows 
a reduction in the median PSQI component 1 value in the 
experimental group after treatment, with an improvement in 
the subjective quality of sleep.
The ingestion of coffee, tea, and chocolate (P > 0.999) did 
not signifi cantly differ between the groups at both the beginning 
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Figure 1 
Median Visual Analogue Scale values according to the groups, 
before and after treatment.
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Figure 2
Median PSQI component 1 values according to the groups, 
before and after treatment.
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Table 2
Description of the sleep quality measures in fi bromyalgia and patient’s assessment according to the groups, before and after
treatment, and result of the comparisons
Variable Group(n = 35)
Initial 3 months
P
Mean SD Median Mean SD Median
Disease duration (years) ControlExperimental
5.45
5.80
4.72
4.32
5.0
5.0
5.47
5.75
4.72
4.33
5.0
5.0
0.317
0.317
VAS (pain) ControlExperimental
7.11
7.66
2.63
1.95
8
8
6.09
6.49
3.53
2.75
8
7
0.131
0.028
Fatigue on the occasion (0:4) ControlExperimental
2.86
3.11
1.22
0.87
3
3
2.71
2.63
1.23
1.09
3
3
0.369
0.021
Sleep satisfaction (0–5) ControlExperimental
3.03
3.43
1.82
1.70
4
4
3.23
3.06
1.72
1.43
4
3
0.456
0.162
Component 1
(Subjective quality of sleep)
Control
Experimental
1.54
1.86
0.74
0.81
2
2
1.66
1.51
0.76
0.89
2
1
0.499
0.030
Component 2
(Sleep latency)
Control
Experimental
1.89
2.06
1.13
1.06
2
2
1.83
1.91
1.36
1.25
3
3
0.908
0.429
Component 3
(Sleep duration)
Control
Experimental
1.11
1.20
0.90
1.11
1
1
1.03
0.94
1.04
1.19
1
0
0.700
0.271
Component 4
(Sleep efﬁ ciency)
Control
Experimental
0.17
0.23
0.57
0.55
0
0
0.20
0.20
0.63
0.47
0
0
0.915
0.792
Component 5
(Sleep disorders)
Control
Experimental
2.17
2.20
0.57
0.53
2
2
1.94
2.09
0.59
0.51
2
2
0.074
0.285
Component 6
(Use of sleeping pills)
Control
Experimental
0.94
1.54
1.35
1.48
0
2 1.231.60
1.46
1.46
0
2
0.164
0.928
Component 7
(Sleep-related daily dysfunctions) 
Control
Experimental
2.14
1.89
1.00
1.02
2
2
1.86
1.74
1.00
0.85
2
2
0.147
0.525
PSQI Control Experimental
9.97
9.74
3.04
3.09
10
10
10.97
10.00
3.52
3.96
11
10
0.664
0.065
FIQ (global score) ControlExperimental
54.59
59.53
16.77
17.98
55.8
63.7
52.75
54.26
18.75
17.86
56.7
56.7
0.768
0.149
VAS = Visual Analogue Scale; PSQI = Pittsburg Sleep Quality Index; FIQ = Fibromyalgia Impact Questionnaire.
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of study and after three months of treatment. Those results were 
obtained by use of Fisher exact test.
After receiving treatment for three months, the experimen-
tal group showed an increase in the percentage of reports of 
“silent environment” (range, 42.9%–68.6%), a reduction in 
the percentage of reports of “fairly quiet environment” (range, 
40%–22.9%), and a reduction in the percentage of reports of 
“noisy environment” (range, 17.1%–8.6%). The control group, 
however, showed an increase in the percentage of reports of 
“noisy environment” (range, 11.4%–17.1%) after three months 
of treatment. Those values, however, showed no statistically 
signifi cant differences (P > 0.05), assessed by use of the likeli-
hood ratio test.
After three months of treatment, the experimental group 
showed an increase in the percentage of reports of “dark envi-
ronment” (range, 34.3%–82.9%) and a decrease in the percent-
age of “poorly lighted environment” (range, 37.1%–5.7%), 
and in the percentage of “well lighted environment” (range, 
28.6%–11.4%). 
Regarding ventilation, after three months of treatment, the 
experimental group showed an increase in the percentage of 
“non-ventilated environment” (range, 20% - 48.6%), stability 
in the percentage of “poorly ventilated environment” (20%), 
and a reduction in the percentage of “well ventilated environ-
ment” (range, 60% - 31.4%).
Table 3 shows that, when using Spearman correlation for 
the changes in the FIQ (fi nal-initial) and the PSQI components 
(fi nal-initial), the result observed is a modifi cation in FIQ 
directly proportional to that of the PSQI component 2 (r = 0.311 
and P = 0.009), corresponding to sleep latency in both groups.
DISCUSSION
The results of this study have shown an improvement in the 
subjective sleep quality and in the results of the pain VAS in 
patients with FM receiving sleep hygiene instructions.
Question 3 of the sleep diary, regarding the number of 
days in which the patient woke up in the middle of the night 
and had no diffi culty falling asleep again, showed a statisti-
cally signifi cant difference, probably due to the instructions 
regarding environmental noise and lighting (performed by 
most patients).
Thus, sleep hygiene provided benefi t in the subjective 
quality of sleep, with an improvement in the PSQI compo-
nent 1 (subjective quality of sleep). When the sleep quality is 
benefi ted, there is also an improvement in pain and fatigue,14 
explaining the reduction in the VAS and fatigue in that group. 
In another study, patients receiving sleep hygiene instructions 
also had favorable results regarding pain and well-being as 
compared with a control group.10 Those fi ndings are in ac-
cordance with those of a recent study15 suggesting a decrease 
in pain in patients with FM obtained through an improvement 
in sleep quality, as in the present study.
Other fi ndings in this study correlated PSQI and FIQ: the 
greater the change in the PSQI component 2, the greater the change 
in FIQ. This means that, when the score of PSQI component 2 
(sleep latency) increases, the total FIQ score also increases. This 
confi rms the importance of assessing sleep quality by use of PSQI, 
when the impact of disease on the quality of life of patients with 
FM is high. In addition, that fi nding translates the importance of 
global assessment, associated with a treatment involving the dif-
ferent factors affected in the life of those patients.
Studies have applied the cognitive-behavioral therapy 
(CBT) to sleep10 and pain16,17 in patients with FM. In their study, 
Edinger et al.10 have concluded that CBT applied to sleep is 
more effective than sleep hygiene instructions, and those two 
interventions are more effective than the medicamentous in-
tervention usually performed in patients with FM. However, 
sleep hygiene has provided favorable results regarding pain 
and mental well-being, as in our study. 
The changes in habits in both groups were not controlled. 
Some variables, such as coffee ingestion, type of food, and 
characteristics of the sleep environment were assessed before 
and after treatment. A statistically signifi cant change was ob-
served only in the sleep environment. Nevertheless, a reduction 
in the pain VAS and fatigue values was observed after treatment 
Table 3
Spearman correlation between the changes in FIQ (fi nal–initial) 
and the changes in the PSQI components (fi nal–initial)
PSQI sleep component (n = 70) Correlation P
Component 1 
(Subjective quality of sleep)
0.116 0.339
Component 2
(Sleep latency)
0.311 0.009
Component 3 
(Sleep duration)
0.104 0.391
Component 4 
(Sleep efﬁ ciency)
0.188 0.119
Component 5 
(Sleep disorders)
0.059 0.629
Component 6 
(Use of sleeping pills)
0.071 0.561
Component 7 
(Sleep-related daily dysfunctions)
0.159 0.189
Spearman correlation test.
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in the experimental group. Thus, it is believed that if other sleep 
hygiene recommendations are followed, the benefi t regarding 
sleep will be even greater, thus improving the quality of life 
and mental health of patients with FM.
CONCLUSION
A booklet with sleep hygiene instructions allowed changing 
the behavior of patients, whose pain and fatigue improved, in-
creasing the subjective quality of sleep, and facilitating falling 
asleep after waking up in the middle of the night.
This study shows that sleep hygiene can benefi t the qual-
ity of sleep of patients with FM. Further studies should be 
conducted, more effectively controlling the changes in the life 
habits of patients practicing sleep hygiene.
The sleep hygiene instructions handed to patients of the 
experimental group were obtained from articles about the 
non-medicamentous treatment of chronic insomnia and treat-
ment of sleep disorders in the elderly. There are few studies 
using those instructions for patients with FM. Thus, there is no 
consensus in the literature about evidence-based instructions 
and those more indicated for that type of patient, limiting the 
results and conclusions.
Neither the medicines used by the patients at the beginning 
of the study nor the medicamentous changes asked by the doc-
tors during the three months of study were controlled, limiting 
the results and the conclusion. In addition, there was no control 
of the baseline characteristics regarding sedentary lifestyle and 
body mass index. This study had no blind examiner, which also 
limited the results and the conclusion.
Melhora da dor, do cansaço e da qualidade subjetiva do sono por meio de orientações de higiene do sono em pacientes com ﬁ bromialgia
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